Skip to main content
GNI Group Ltd. logo

GNI Group Ltd. — Investor Relations & Filings

Ticker · 2160 ISIN · JP3386370005 LEI · 5299005KSTCN0WVJMQ52 T Manufacturing
Open in API
Filings indexed 93 across all filing types
Latest filing 2021-03-31 Regulatory Filings
Country JP Japan
Listing T 2160

About GNI Group Ltd.

https://www.gnipharma.com/

GNI Group Ltd. is a vertically integrated, multinational biopharmaceutical company engaged in the full spectrum of drug development, from research and clinical trials to manufacturing, sales, and marketing. The company's portfolio includes pharmaceutical drugs, traditional Chinese medicines, and medical devices. Its research and development efforts are primarily focused on creating therapies for diseases such as cancer and inflammation, with a particular emphasis on conditions prevalent in Asian populations. The group utilizes genetic information and analysis technology to advance its drug discovery programs.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の４の２第１項' (Article 24-4-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of the company's annual securities report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 2020
2021-03-31 Japanese
内部統制報告書－第20期(令和2年1月1日－令和2年12月31日)
Governance Information Classification · 100% confidence The document is titled '内部統制報告書' (Internal Control Report) and cites the '金融商品取引法' (Financial Instruments and Exchange Act) as its legal basis. This is a specific regulatory filing required in Japan to report on the effectiveness of internal controls over financial reporting. Since it is a standalone report on internal controls rather than a full annual report (10-K) or a general regulatory announcement (RNS), and it does not fit into the other specific categories like audit reports (AR) or governance (CGR), it is best classified as a Regulatory Filing (RNS) as it is a mandatory statutory disclosure.
2021-03-31 Japanese
有価証券報告書－第20期(令和2年1月1日－令和2年12月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains detailed financial statements, management discussion, and corporate information for the fiscal year ending December 31, 2020. The document header explicitly identifies it as a 'Securities Report' filed under the Financial Instruments and Exchange Act. FY 2020
2021-03-31 Japanese
四半期報告書－第20期第3四半期(令和2年7月1日－令和2年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the third quarter of the 20th fiscal period, covering the period from July 1, 2020, to September 30, 2020. It includes detailed financial statements, management analysis (MDA), and research/development updates, which are characteristic of a formal interim/quarterly financial report filed under the Financial Instruments and Exchange Act in Japan. It is not an announcement or a summary, but the full report itself. 9M 2020
2020-11-13 Japanese
四半期報告書－第20期第2四半期(令和2年4月1日－令和2年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for GNI Group Ltd., covering the period from April 1, 2020, to June 30, 2020. It contains detailed financial statements, management analysis (MDA), and operational updates, which are characteristic of an interim/quarterly report. It is not a mere announcement or certification, as it provides substantive financial data and analysis. H1 2020
2020-08-14 Japanese
四半期報告書－第20期第1四半期(令和2年1月1日－令和2年3月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the first quarter of the 20th fiscal year (January 1, 2020, to March 31, 2020) for GNI Group Ltd. It contains detailed financial statements, management analysis (MDA), and business status updates, which are characteristic of an Interim/Quarterly Report. It is not a mere announcement (RPA) as it contains substantive financial data and analysis. Q1 2020
2020-05-15 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.